Trial intelligence / Profile preview

Albumin during cardiopulmonary bypass for prevention of acute renal dysfunction after cardiac surgery

2017-003027-30Phase 4Completed

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Sep 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of albumin (human) in acute kidney failure (AKF) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Incidence of acute renal dysfunction associated with cardiac surgery. Started Sep 2017; status: completed.

02

Drugs

albumin (human)
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on 2017-003027-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003027-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call